Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|13|1|26-54

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.1, 2013-01, pp. : 26-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

By Heresco-Levy Uriel  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 827-844

Informa Healthcare

Access to resources Recommend Favorite

AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3536-3565

Bentham Science Publishers

Access to resources Recommend Favorite

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 219-238

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamatergic Animal Models of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1593-1604

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 94-102

Bentham Science Publishers

Access to resources Recommend Favorite